<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        28-222-09
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2009
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        CO AMOX  1000MG F.C. TABLETS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        AMOXICILLIN,CLAVULANIC ACID
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        875,125
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        14
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        49.60
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="SANDOZ" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            SANDOZ
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            ACINO PHARMA AG
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01CR02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>CoAmox is an antibiotic and works by killing<br />bacteria that cause infections. It contains two<br />different medicines called amoxicillin and<br />clavulanic acid. Amoxicillin belongs to a group<br />of medicines called &ldquo;penicillins&rdquo; that can sometimes<br />be stopped from working (made inactive).<br />The other active component (clavulanic acid)<br />stops this from happening.<br />CoAmox is used in adults and children to treat<br />the following infections:<br />&bull; middle ear and sinus infections<br />&bull; respiratory tract infections<br />&bull; urinary tract infections<br />&bull; skin and soft tissue infections including<br />dental infections<br />&bull; bone and joint infections.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>a. Do not take CoAmox:<br />&bull; if you are allergic to amoxicillin, clavulanic<br />acid, penicillin or any of the other ingredients<br />of this medicine (listed in section 6).<br />&bull; if you have ever had a severe allergic reaction<br />to any other antibiotic. This can include<br />a skin rash or swelling of the face or throat.<br />&bull; if you have ever had liver problems or jaundice<br />(yellowing of the skin) when taking an<br />antibiotic.<br /> Do not take CoAmox if any of the above<br />apply to you. If you are not sure, talk to your<br />doctor or pharmacist before taking CoAmox.<br />b. Take special care with CoAmox<br />Talk to your doctor or pharmacist before taking<br />CoAmox if you:<br />&bull; have glandular fever<br />&bull; are being treated for liver or kidney problems<br />&bull; are not passing water regularly.<br />If you are not sure if any of the above apply to<br />you, talk to your doctor or pharmacist before<br />taking CoAmox.<br />In some cases, your doctor may investigate the<br />type of bacteria that is causing your infection.<br />Depending on the results, you may be given a<br />different strength of CoAmox or a different medicine.<br />Conditions you need to look out for<br />CoAmox can make some existing conditions<br />worse, or cause serious side effects. These include<br />allergic reactions, convulsions (fits) and<br />inflammation of the large intestine. You must<br />look out for certain symptoms while you are<br />taking CoAmox, to reduce the risk of any problems.<br />See &lsquo;Conditions you need to look out for&rsquo;<br />in Section 4.<br />Blood and urine tests<br />If you are having blood tests (such as red blood<br />cell status tests or liver function tests) or urine<br />tests (for glucose), let the doctor or nurse know<br />that you are taking CoAmox. This is because<br />CoAmox can affect the results of these types of<br />tests.<br />c. Taking other medicines and CoAmox<br />Tell your doctor or pharmacist if you are using or<br />have recently used or might use any other medicines.<br />If you are taking allopurinol (used for gout) with<br />CoAmox, it may be more likely that you will<br />have an allergic skin reaction.<br />If you are taking probenecid (used for gout),<br />your doctor may decide to adjust your dose of<br />CoAmox.<br />If medicines to help stop blood clots (such as<br />warfarin) are taken with CoAmox then extra<br />blood tests may be needed.<br />CoAmox can affect how methotrexate (a medicine<br />used to treat cancer or rheumatic diseases)<br />works.<br />CoAmox can affect how mycophenolate mofetil<br />(a medicine used to prevent the rejection of<br />transplanted organs) works.<br />d. Pregnancy, breast-feeding and fertility<br />If you are pregnant or breast-feeding, think you<br />may be pregnant or are planning to have a baby,<br />ask your doctor or pharmacist for advice before<br />taking this medicine.<br />e. Driving and using machines<br />CoAmox can have side effects and the symptoms<br />may make you unfit to drive. Do not drive<br />or operate machinery unless you are feeling<br />well.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Swallow the tablets whole with a glass of<br />water with a meal.<br />Tablets can be broken along the score line to<br />make them easier to swallow. You must take<br />both pieces of the tablet at the same time.<br />&bull; Space the doses evenly during the day, at<br />least 4 hours apart. Do not take 2 doses in<br />1 hour.<br />&bull; Do not take CoAmox for more than 2 weeks.<br />If you still feel unwell you should go back to<br />see the doctor.<br />a. If you take more CoAmox than you should<br />If you take too much CoAmox, signs might include<br />an upset stomach (feeling sick, being sick<br />or diarrhoea) or convulsions. Talk to your doctor<br />as soon as possible. Take the medicine carton or<br />bottle to show the doctor.<br />b. If you forget to take CoAmox<br />If you forget to take a dose, take it as soon as<br />you remember. You should not take the next<br />dose too soon, but wait about 4 hours before<br />taking the next dose. Do not take a double dose<br />to make up for a forgotten dose.<br />c. If you stop taking CoAmox<br />Keep taking CoAmox until the treatment is finished,<br />even if you feel better. You need every dose<br />to help fight the infection. If some bacteria survive<br />they can cause the infection to come back.<br />If you have any further questions on the use of<br />this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side<br />effects, although not everybody gets them. The<br />side effects below may happen with this medicine.<br />Conditions you need to look out for<br />Allergic reactions:<br />&bull; skin rash<br />&bull; inflammation of blood vessels (vasculitis)<br />which may be visible as red or purple raised<br />spots on the skin, but can affect other parts<br />of the body<br />&bull; fever, joint pain, swollen glands in the neck,<br />armpit or groin<br />&bull; swelling, sometimes of the face or throat<br />(angioedema), causing difficulty in breathing<br />&bull; collapse.</p><p> Contact a doctor immediately if you get<br />any of these symptoms. Stop taking<br />CoAmox.<br />Inflammation of large intestine<br />Inflammation of the large intestine, causing watery<br />diarrhoea usually with blood and mucus,<br />stomach pain and/or fever.<br /> Contact your doctor as soon as possible<br />for advice if you get these symptoms.<br />Very common side effects<br />These may affect more than 1 in 10 people<br />&bull; diarrhoea (in adults).<br />Common side effects<br />These may affect up to 1 in 10 people<br />&bull; thrush (candida &ndash; a yeast infection of the<br />vagina, mouth or skin folds)<br />&bull; feeling sick (nausea), especially when taking<br />high doses<br /> if affected take CoAmox with a meal<br />vomiting<br />&bull; diarrhoea (in children).<br />Uncommon side effects<br />These may affect up to 1 in 100 people<br />&bull; skin rash, itching<br />&bull; raised itchy rash (hives)<br />indigestion<br />&bull; dizziness<br />&bull; headache.<br />Uncommon side effects that may show up in<br />your blood tests:<br />&bull; increase in some substances (enzymes)<br />produced by the liver.<br />Rare side effects<br />These may affect up to 1 in 1000 people<br />&bull; skin rash, which may blister, and looks like<br />small targets (central dark spots surrounded<br />by a paler area, with a dark ring around the<br />edge &ndash; erythema multiforme)<br /> if you notice any of these symptoms contact<br />a doctor urgently.<br />Rare side effects that may show up in your<br />blood tests:<br />&bull; low number of cells involved in blood clotting<br />&bull; low number of white blood cells.<br />Frequency not known<br />Frequency cannot be estimated from the available<br />data.<br />&bull; Allergic reactions (see above)<br />&bull; Inflammation of the large intestine (see<br />above)<br />&bull; Inflammation of the protective membrane<br />surrounding the brain (aseptic meningitis)<br />&bull; Serious skin reactions:<br />- a widespread rash with blisters and<br />peeling skin, particularly around the<br />mouth, nose, eyes and genitals (Stevens-<br />Johnson syndrome), and a more severe<br />form, causing extensive peeling of the<br />skin (more than 30% of the body surface<br />&ndash; toxic epidermal necrolysis)<br />- widespread red skin rash with small<br />pus-containing blisters (bullous exfoliative<br />dermatitis)<br />- a red, scaly rash with bumps under the<br />skin and blisters (exanthemous pustulosis).<br />- flu-like symptoms with a rash, fever,<br />swollen glands, and abnormal blood test<br />results (including increased white blood<br />cells (eosinophilia) and liver enzymes)<br />(Drug Reaction with Eosinophilia and<br />Systemic Symptoms (DRESS)).<br /> Contact a doctor immediately if you get<br />any of these symptoms.<br />&bull; inflammation of the liver (hepatitis)<br />&bull; jaundice, caused by increases in the blood<br />of bilirubin (a substance produced in the<br />liver) which may make your skin and whites<br />of the eyes appear yellow<br />&bull; inflammation of tubes in the kidney<br />&bull; blood takes longer to clot<br />&bull; hyperactivity<br />&bull; convulsions (in people taking high doses of<br />CoAmox or who have kidney problems)<br />&bull; black tongue which looks hairy<br />Side effects that may show up in your blood or<br />urine tests:<br />&bull; severe reduction in the number of white<br />blood cells<br />&bull; low number of red blood cells (haemolytic<br />anaemia)<br />&bull; crystals in urine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of<br />children.<br />Do not use this medicine after the expiry date<br />which is stated on the carton. The expiry date<br />refers to the last day of that month.<br />Do not store above 30&deg; C.<br />Store in the original package in order to protect<br />from moisture.<br />Do not use if the tablets are chipped or damaged.<br />Do not throw away any medicines via wastewater<br />or household waste. Ask your pharmacist<br />how to throw away medicines you no longer<br />use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>. What CoAmox contains<br />&bull; The active substances are amoxicillin and<br />clavulanic acid. Each tablet contains amoxicillin<br />trihydrate equivalent to 875 mg amoxicillin<br />and potassium clavulanate equivalent<br />to 125 mg of clavulanic acid.<br />&bull; The other ingredients are: Tablet core &ndash;<br />Colloidal silicon dioxide, Crospovidone, dried,<br />Crosslinked carboxymethylcellulose sodium<br />dried, Magnesium stearate &amp; Microcrystalline<br />Cellulose, dried.<br />Film-coat &ndash; Hydropropoxycellulose, Ethylcellulose,<br />Polysorbate, Triethylcitrate, Titanium<br />dioxide, Talc.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                CoAmox 1000 mg film coated tablets are white
to off-white, oblong film coated tablet with
beveled edges, scored and debossed with
875/125 on one side and debossed with AMC
on the other side.
They are packaged in blister packs, enclosed in
a carton. Each pack contains 12 tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorisation Holder:<br />Acino Pharma AG, Liesberg, Switzerland.<br />Manufacturer:<br />Lek, Prevalje, Slovenia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                June 2018
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>يُعد كوأموكس مضادًّا حيويًّا، يعمل من خلال القضاء على<br />البكتيريا التي تُسبب العدوى. ويحتوي على دواءين مختلفين<br />هما أموكسيسيلّين وحمض الكلافيولانيك. ينتمي أموكسيسيلّين<br />إلى مجموعة من الأدوية تُسمى &ldquo;بنسلينات&rdquo; والتي من الممكن<br />إبطال مفعولها أحيانًا )جعلها غير نشطة(. يعمل المكون النَّشط<br />الآخر )حمض الكلافيولانيك( على منع حدوث ذلك.<br />يُستخدم كوأموكس في البالغين والأطفال لعلاج العدوى التَّالية:<br />&bull; عدوى الأذن الوسطى وعدوى الجيوب الأنفية<br />&bull; عدوى الجهاز التَّنفسي<br />&bull; عدوى الجهاز البولي<br />&bull; عدوى الجلد والأنسجة الرخوة بما في ذلك عدوى الأسنان<br />&bull; عدوى العظام والمفاصل.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>أ . لا تتناول كوأموكس في الحالات الآتية:<br />&bull; إذا كنت تعاني من حساسية تجاه أموكسيسيلّين، أو حمض<br />الكلافيولانيك، أو البنسيلين أو تجاه أي من المكونات الأخرى<br />.) بهذا الدَّواء )المدرجة في قسم: 6<br />&bull; إذا كنت قد عانيت من قبل من تفاعل حساسية شديد<br />تجاه أي مضاد حيوي آخر. وقد يشمل ذلك طفحًا جلديًّا أو<br />تورم الوجه أو الحَلْق.<br />&bull; إذا عانيت من قبل من مشاكل بالكبد أو من اليرقان<br />)اصفرار الجلد( عند تناول أحد المضادات الحيوية.<br />يُحظر استخدام كوأموكس إذا انطبق عليك أي مما سبق. <br />إذا لم تكن متأكدًا، تحدَّث مع طبيبك أو الصيدلي الخاص بك<br />قبل تناول كوأموكس.<br />ب . توخ حذرًا خاصًّا مع كوأموكس<br />تحدَّث إلى طبيبك أو الصيدلي الخاص بك قبل تناول كوأموكس<br />في الحالات الآتية:<br />&bull; إذا كنت تعاني من حمى غدية.<br />&bull; إذا كنت تخضع للعلاج بسبب مشاكل الكبد أو الكُلى.<br />&bull; إذا لم تكن تتبول بشكل منتظم.<br />إذا لم تكن متأكدًا مما إذا كان أي من السَّابق ينطبق عليك،<br />تحدَّث إلى طبيبك أو الصيدلي الخاص بك قبل تناول كوأموكس.<br />في بعض الحالات، قد يتحقق طبيبك من نوع البكتيريا المسببة<br />للعدوى لديك. بناءً على النتائج، قد يتم إعطاؤك تركيزًا مختلفًا<br />من كوأموكس أو دواءً آخر.<br />حالات ينبغي توخي الحذر منها<br />قد يتسبب كوأموكس في تفاقم بعض الحالات المرضية القائمة،<br />أو قد يسبب آثارًا جانبية خطيرة. وتشمل هذه الآثار تفاعلات<br />حساسية، تشنجات )نوبات تشنجية( والتهاب الأمعاء الغليظة.<br />ينبغي عليك توخي الحذر من أعراض معينة أثناء تناولك<br />لكوأموكس؛ للحد من فرص حدوث أي مشاكل. انظر &ldquo;حالات<br />. ينبغي توخي الحذر منها&rdquo; في قسم 4<br />اختبارات الدَّم والبول<br />إذا كنت ستخضع لاختبارات دم )مثل اختبارات لتقييم حالة<br />خلايا الدَّم الحمراء أو اختبارات وظائف الكبد( أو اختبارات<br />بول )للجلوكوز(، احرص على إبلاغ الطبيب أو الممرض)ة(<br />بتناولك لكوأموكس. وذلك لأنَّ كوأموكس قد يُؤثر على نتائج<br />هذا النوع من الاختبارات.<br />ج . تناوُل أدوية أخرى مع كوأموكس<br />يُرجى إبلاغ طبيبك أو الصيدلي الخاص بك إذا كنت تستخدم أو<br />استخدمت مؤخرًا أو قد تستخدم أيَّة أدوية أخرى.<br />إذا كنت تتناول ألوبيورينول )يُستخدم لعلاج مرض النقرس(<br />بالتَّزامن مع كوأموكس، فقد تكون أكثر عُرضة للإصابة بتفاعل<br />حساسية بالجلد.<br />إذا كنت تتناول بروبنيسيد )يُستخدم لعلاج مرض النقرس(، قد<br />يقرر طبيبك تعديل جرعتك من كوأموكس.<br />إذا كنت تتناول أدوية للمساعدة في الوقاية من حدوث<br />الجلطات الدَّموية )مثل وارفارين( بالتَّزامن مع كوأموكس، فقد<br />تكون بحاجة للخضوع لاختبارات دمٍ إضافية.<br />قد يُؤثر كوأموكس على كيفية عمل ميثوتريكسات )أحد الأدوية<br />التي تُستخدم لعلاج السرطان أو الأمراض الروماتيزمية(.<br />قد يُؤثر كوأموكس على كيفية عمل مَيكوفينوليت موفيتيل<br />)أحد الأدوية التي تُستخدم لتجنب رفض الأعضاء المزروعة(.<br />د . الحمل والرَّضاعة الطبيعية والخصوبة<br />إذا كنتِ حاملً أو مرضعًا، أو تعتقدين أنكِ حامل أو تخططين<br />للحمل، فاستشيري طبيبك أو الصيدلي الخاص بك قبل تناول<br />هذا الدَّواء.<br />ه . القيادة واستخدام الآلات<br />قد ينجم عن كوأموكس آثار جانبية وقد تجعلك الأعراض غير<br />قادرٍ على القيادة. لا تمارس القيادة أو تشغل الآلات ما لم تكن<br />على ما يرام.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تناول دائمًا هذا الدَّواء بالضبط كما أخبرك طبيبك أو الصيدلي<br />الخاص بك. راجع طبيبك أو الصيدلي الخاص بك إذا لم تكن<br />متأكدًا من كيفية الاستخدام.<br />البالغون والأطفال ممن يزنون 40 كجم وأكثر<br />&bull; الجرعة المعتادة &ndash; قرص واحد مرتين في اليوم<br />&bull; الجرعة الأعلى &ndash; قرص واحد ثلاث مرات في اليوم<br />الأطفال ممن تقل أوزانهم عن 40 كجم<br />يُفضَّل أن يُعالج الأطفال ممن يبلغون 6 أعوام أو أقل بمعلَّق<br />فموي أو أكياس من كوأموكس. استشر طبيبك أو الصيدلي<br />الخاص بك عند إعطاء أقراص كوأموكس للأطفال ممن تقل<br />أوزانهم عن 40 كجم. تُعد الأقراص غير مناسبة للأطفال ممن<br />تقل أوزانهم عن 25 كجم.<br />المرضى ممن يعانون من مشاكل بالكُلى والكبد<br />&bull; إذا كنت تعاني من مشاكل بالكلى فقد تتغير الجرعة. قد<br />يختار طبيبك تركيزًا مختلفًا أو دواءً آخر.<br />&bull; إذا كنت تعاني من مشاكل بالكبد فقد تخضع لاختبارات<br />الدَّم بشكل أكثر تكرارًا؛ وذلك للتَّحقق من مدى كفاءة عمل<br />الكبد لديك.<br />كيفية تناول كوأموكس<br />&bull; ابتلع الأقراص كاملة مع كوب من الماء مع وجبة.<br />&bull; يمكن كسر الأقراص على امتداد خط الحز لتيسير بلعها.<br />يجب عليك تناول قطعتي القرص في الوقت نفسه.<br />&bull; احرص على وجود فواصل زمنية متساوية بين الجرعات أثناء<br />النهار، على أن تبلغ 4 ساعات على الأقل. لا تتناول جرعتين<br />خلال ساعة واحدة.<br />&bull; لا تتناول كوأموكس لأكثر من أسبوعين. إذا كنت لا تزال<br />تشعر بالمرض، ينبغي عليك العودة لزيارة الطبيب.<br />أ . إذا تناولت كمية أكثر مما يجب من كوأموكس<br />إذا تناولت كمية أكبر مما يجب من كوأموكس، قد تشمل<br />العلامات تهيُّج المعدة )شعورًا بالإعياء، إعياء أو إسها لً( أو<br />تشنجات. أخبر طبيبك في أسرع وقت ممكن. خذ معك عبوة<br />الدَّواء أو زجاجته كي تريها للطبيب.<br />ب .إذا أغفلت تناول كوأموكس<br />إذا أغفلت تناول جرعة، فتناولها بمجرد تذكرك لها. ينبغي عليك<br />عدم تناول الجرعة التَّالية في وقتٍ قريب، بل انتظر 4 ساعات<br />تقريبًا قبل تناول الجرعة التَّالية. لا تتناول جرعة مضاعفة<br />لتعويض جرعة أغفلتها.<br />ج . إذا توقفت عن تناول كوأموكس<br />استمر في تناول كوأموكس حتى انتهاء العلاج، حتى وإن<br />شعرت بتحسن. أنت بحاجة إلى كل جرعة؛ لتساعدك على<br />مقاومة العدوى. إذا نجت بعض البكتيريا، فقد يتسبب ذلك في<br />عودة العدوى.<br />إذا كانت لديك أية أسئلة إضافية حول استخدام هذا الدَّواء،<br />فاستشر طبيبك أو الصيدلي الخاص بك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثله مثل كافة الأدوية، قد يُسبب هذا الدَّواء آثارًا جانبية، على<br />الرَّغم من عدم حدوثها لدى الجميع. قد تحدث الآثار الجانبية<br />أدناه مع هذا الدَّواء.<br />حالات ينبغي توخي الحذر منها<br />تفاعلات الحساسية:<br />&bull; الطفح الجلدي<br />&bull; التهاب الأوعية الدَّموية والذي قد يظهر على هيئة بقع<br />بارزة حمراء أو أرجوانية بالجلد، لكنه قد يُؤثر في أجزاء<br />أخرى من الجسم.<br />&bull; حمى، ألم بالمفاصل، تورم الغدد بالرقبة، الإبط أو الأربية.<br />&bull; تورم، أحيانًا بالوجه أو الحلق )وذمة وعائية( مما قد يُسبب<br />صعوبة في التَّنفس.<br />&bull; هبوط.<br />أخبر طبيبًا على الفور إذا تعرضت للإصابة بأي من هذه <br />الأعراض. توقف عن تناول كوأموكس.<br />التهاب الأمعاء الغليظة<br />التهاب الأمعاء الغليظة، مما يتسبب في إسهال مائي يكون<br />مصحوبًا عادةً بدم ومخاط، ألم بالمعدة و/أو حمى.<br />أخبر طبيبك في أسرع وقت ممكن إذا عانيت من <br />هذه الأعراض.<br />آثار جانبية شائعة جدًّا<br />قد تُؤثر هذه على أكثر من شخص واحد من بين كل 10 أشخاص<br />&bull; إسهال )في البالغين(.<br />آثار جانبية شائعة<br />قد تُؤثر هذه على ما يصل إلى شخص واحد من بين<br />كل 10 أشخاص<br />&bull; سُلَق )المبيضة &ndash; عدوى فطرية بالمهبل، بالفم أو بثنيات<br />الجلد(.</p><p>&bull; الشعور بالإعياء )غثيان(، خاصةً عند تناول جرعات مرتفعة.<br />إذا أُصبت بها، تناول كوأموكس مع وجبة. &szlig;<br />&bull; قيء.<br />&bull; إسهال )في الأطفال(.<br />آثار جانبيَّة غير شائعة<br />قد تُؤثر هذه على ما يصل إلى شخص واحد من بين كل<br />100 شخص<br />&bull; طفح جلدي، حكة.<br />&bull; طفح جلدي بارز مصحوب بحكة )أرتكاريا(.<br />&bull; عسر الهضم.<br />&bull; دوخة.<br />&bull; صداع.<br />آثار جانبية غير شائعة قد تظهر في اختبارات الدَّم لديك:<br />&bull; زيادة في بعض المواد )إنزيمات( التي يفرزها الكبد.<br />آثار جانبيَّة نادرة<br />قد تُؤثر هذه على ما يصل إلى شخص واحد من بين كل<br />1000 شخص<br />&bull; طفح جلدي، والذي قد يُؤدي إلى ظهور بثور، ويبدو<br />كأهداف صغيرة )بقع داكنة مركزية تحيط بها منطقة أكثر<br />شحوبًا، مع حلقة داكنة حول الحواف &ndash; احمرار متعدد<br />الأشكال(.<br />اتصل بطبيب بشكلٍ عاجل إذا لاحظت ظهور أيٍّ من هذه <br />الأعراض.<br />آثار جانبية نادرة قد تظهر في اختبارات الدَّم لديك:<br />&bull; انخفاض عدد الخلايا التي لها دور في تجلط الدَّم.<br />&bull; انخفاض عدد خلايا الدَّم البيضاء.<br />نسبة التكرار غير معروفة<br />لا يمكن تقدير معدل التكرار من واقع البيانات المتاحة.<br />&bull; تفاعلات حساسية )انظر أعلاه(<br />&bull; التهاب الأمعاء الغليظة )انظر أعلاه(<br />&bull; التهاب الغشاء الحامي المحيط بالمخ )التهاب السحاي ا<br />غير الصديدي(.<br />&bull; تفاعلات جلدية خطيرة:<br />&bull; طفح جلدي واسع الانتشار مصحوب ببثور وتقشر الجلد،<br />تحديدًا حول الفم، الأنف، العينين والأعضاء التناسلية<br />)متلازمة ستيفنز جونسون(، وشكل من الأشكال الأكثر شدة<br />الذي يُسبب تقشرًا واسعًا بالجلد )أكثر من 30 ٪ من سطح<br />الجسم - انحلال البشرة النخري التَّسَمُّمِيّ(.<br />&bull; طفح جلدي أحمر واسع الانتشار مصحوب ببثور صغيرة بها<br />صديد )التهاب الجلد التقشري الفقاعي(.<br />&bull; طفح جلدي حرشفي أحمر مصحوب بنتوءات تحت الجلد<br />وبثور )البُثار الطفحي(.<br />أعراض شبيهة بأعراض الأنفلونزا مصحوبة بطفح جلدي، حمى،<br />تورم الغدد، ونتائج غير طبيعية في اختبارات الدَّم )بما في<br />ذلك زيادة خلايا الدَّم البيضاء )كثرة خلايا اليُوزينِيَّات(<br />وإنزيمات الكبد( )الطفح الجلدي الدَّوائي المصحوب بكثرة<br />خلايا اليُوزينِيَّات وأعراض جهازية(.<br />أخبر طبيبًا على الفور إذا تعرضت للإصابة بأي من هذه <br />الأعراض.<br />&bull; التهاب الكبد.<br />&bull; اليرقان، النَّاجم عن زيادة في البيليروبين بالدَّم )مادة يتم<br />تصنيعها في الكبد( مما قد يتسبب في أن يبدو الجلد وبياض<br />العينين لديك بلون أصفر.<br />&bull; التهاب الأنابيب بالكُلى.<br />&bull; استغراق الدَّم وقتًا أطول كي يتجلط.<br />&bull; فرط النَّشاط.<br />&bull; تشنجات )في الأشخاص ممن يتناولون جرعات مرتفعة من<br />كوأموكس أو ممن يعانون من مشاكل بالكُلى(.<br />&bull; لسان أسود يبدو وكأنه مكسو بالشعر.<br />آثار جانبية قد تظهر في اختبارات الدَّم أو البول لديك:<br />&bull; انخفاض شديد في عدد خلايا الدَّم البيضاء.<br />&bull; انخفاض عدد خلايا الدَّم الحمراء )فقر الدَّم الانحلالي(.<br />&bull; وجود بلورات بالبول.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يُحفظ هذا الدَّواء بعيدًا عن رؤية ومُتناوَل الأطفال.<br />لا تستخدم هذا الدَّواء بعد تاريخ انتهاء الصلاحية المذكور على<br />العبوة الكرتونيَّة. يُشير تاريخ انتهاء الصَّلاحية إلى اليوم الأخير<br />من ذلك الشهر.<br />لا تقم بالتَّخزين في درجة حرارة تتعدى 30 درجة مئوية.<br />يجب التَّخزين داخل العبوة الأصلية؛ للحماية من الرطوبة.<br />لا تستخدمه في حال كانت الأقراص بها كسر أو تلف.<br />لا تتخلص من الأدوية عن طريق إلقائها في مياه الصَّف أو<br />مع المخلفات المنزلية. استشر الصيدلي الخاص بك عن كيفية<br />التَّخلص من الأدوية التي لم تَعُد تستخدمها. ستُساعد هذه<br />الإجراءات في الحفاظ على البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادتان الفعالتان هما أموكسيسيلّين وحمض الكلافيولانيك.<br />يحتوي كل قرص على أموكسيسيلّين ثلاثي الهيدرات ما يعادل<br />875 مجم من أموكسيسيلّين، وكلافيولانات البوتاسيوم ما<br />يعادل 125 مجم من حمض الكلافيولانيك.<br />&bull; المكونات الأخرى هي: محتوى القرص الدَّاخلي - ثاني أكسيد<br />السيليكون الغروي، كروسبوفيدون، مجفف، كاربوكسي<br />ميثيل سليلوز الصوديوم المترابط مجفف، ستيرات<br />الماغنسيوم وسليلوز دقيق التَّبلور، مجفف.<br />الغلاف &ndash; هيدروكسي بروبيل السليلوز، إيثيل السليلوز،<br />بوليسوربات، سيترات ثلاثي الإيثيل، ثاني أكسيد التيتانيوم، تلك.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>كوأموكس 1000 مجم أقراص مغلَّفة عبارة عن قرص مغلف<br />لونه أبيض إلى الأبيض المائل للصفرة، مستطيل الشَّكل،<br />875/ مشطوف الحواف، محزز ومحفور على أحد جانبيه 125<br />.&rdquo;AMC&ldquo; وعلى الجانب الآخر<br />يتم تعبأتها في شرائط، ثم وضعها في عبوة كرتونية. تحتوي كل<br />عبوة على 12 قرصًا.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>مالك حق التَّسويق:<br />شركة أسينو فارما شركة مساهمة، ليزبرج، سويسرا<br />جهة التَّصنيع:<br />ليك، بريفالجه، سلوفينيا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            يونيو 2018
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                CoAmox 1000 mg Film coated tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Active substance(s)
Each film-coated tablet contains amoxicillin trihydrate equivalent to 875 mg amoxicillin and
potassium clavulanate equivalent to 125 mg of clavulanic acid.
Excipients
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablet
CoAmox 1000 mg film coated tablets are white to off-white, oblong film coated tablet with
beveled edges, scored and debossed with 875/125 on one side and debossed with AMC on
the other side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>CoAmox is indicated for the treatment of the following infections in adults and children (see<br />sections 4.2, 4.4 and 5.1):<br />&bull; Acute bacterial sinusitis (adequately diagnosed)<br />&bull; Acute otitis media<br />&bull; Acute exacerbations of chronic bronchitis (adequately diagnosed)<br />&bull; Community acquired pneumonia<br />&bull; Cystitis<br />&bull; Pyelonephritis<br />&bull; Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess<br />with spreading cellulitis<br />&bull; Bone and joint infections, in particular osteomyelitis.<br />Consideration should be given to official guidance on the appropriate use of antibacterial<br />agents.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br />Doses are expressed throughout in terms of amoxicillin/clavulanic acid content except when<br />doses are stated in terms of an individual component.<br />The dose of CoAmox that is selected to treat an individual infection should take into account:<br />&bull; The expected pathogens and their likely susceptibility to antibacterial agents (see section<br />4.4)<br />&bull; The severity and the site of the infection<br />&bull; The age, weight and renal function of the patient as shown below.<br />The use of alternative presentations of CoAmox (e.g. those that provide higher doses of<br />amoxicillin and/or different ratios of amoxicillin to clavulanic acid) should be considered as<br />necessary (see sections 4.4 and 5.1).<br />For adults and children &ge; 40 kg, this formulation of CoAmox provides a total daily dose of<br />1750 mg amoxicillin/ 250 mg clavulanic acid with twice daily dosing and 2625 mg<br />amoxicillin/375 mg clavulanic acid with three times daily dosing, when administered as<br />recommended below. For children &lt; 40 kg, this formulation of CoAmox provides a<br />maximum daily dose of 1000-2800 mg amoxicillin/143-400 mg clavulanic acid, when<br />administered as recommended below. If it is considered that a higher daily dose of<br />amoxicillin is required, it is recommended that another preparation of CoAmox is selected in<br />order to avoid administration of unnecessarily high daily doses of clavulanic acid (see<br />sections 4.4 and 5.1).<br />The duration of therapy should be determined by the response of the patient. Some infections<br />(e.g. osteomyelitis) require longer periods of treatment. Treatment should not be extended<br />beyond 14 days without review (see section 4.4 regarding prolonged therapy).<br />Adults and children &ge; 40 kg<br />Recommended doses:<br />&bull; standard dose (for all indications): 875 mg/125 mg two times a day;<br />&bull; higher dose (particularly for infections such as otitis media, sinusitis, lower respiratory tract<br />infections and urinary tract infections): 875 mg/125 mg three times a day.<br />Children &lt; 40 kg<br />Children may be treated with CoAmox tablets, suspensions or paediatric sachets.<br />Recommended doses:<br />&bull; 25 mg/3.6 mg/kg/day to 45 mg/6.4 mg/kg/day given as two divided doses;<br />&bull; up to 70 mg/10 mg/kg/day given as two divided doses may be considered for some<br />infections (such as otitis media, sinusitis and lower respiratory tract infections).<br />As the tablets cannot be divided children weighing less than 25 kg must not be treated with<br />CoAmox tablets.<br />The table below presents the received dose (mg/kg body weight) in children weighing 25 kg<br />to 40 kg upon administering a single 875 mg/125 mg tablet.</p><p>Children weighing less than 25 kg should preferably be treated with CoAmox suspension or<br />paediatric sachets.<br />No clinical data are available for CoAmox 7:1 formulations regarding doses higher than 45<br />mg/6.4 mg per kg per day in children under 2 years<br />There are no clinical data for CoAmox 7:1 formulations for patients under 2 months of age.<br />Dosing recommendations in this population therefore cannot be made.<br />No dose adjustment is considered necessary.<br />Elderly<br />No dose adjustment is required in patients with creatinine clearance (CrCl) greater than 30<br />ml/min.<br />Renal impairment<br />In patients with creatinine clearance less than 30 ml/min, the use of CoAmox presentations<br />with an amoxicillin to clavulanic acid ratio of 7:1 is not recommended, as no<br />recommendations for dose adjustments are available.<br />Dose with caution and monitor hepatic function at regular intervals (see sections 4.3 and 4.4).<br />Hepatic impairment<br />CoAmox is for oral use.<br />Method of administration<br />CoAmox should be administered with a meal to minimise potential gastrointestinal<br />intolerance.<br />Therapy can be started parenterally according to the SmPC of the IV formulation and<br />continued with an oral preparation.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substances, to any of the penicillins or to any of the excipients
listed in section 6.1.
History of a severe immediate hypersensitivity reaction (e.g. anaphylaxis) to another betalactam
agent (e.g. a cephalosporin, carbapenem or monobactam).
History of jaundice/hepatic impairment due to amoxicillin/clavulanic acid (see section 4.8).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Before initiating therapy with amoxicillin/clavulanic acid, careful enquiry should be made<br />concerning previous hypersensitivity reactions to penicillins, cephalosporins or other betalactam<br />agents (see sections 4.3 and 4.8).<br />Serious and occasionally fatal hypersensitivity reactions (including anaphylactoid and severe<br />cutaneous adverse reactions) have been reported in patients on penicillin therapy. These<br />reactions are more likely to occur in individuals with a history of penicillin hypersensitivity<br />and in atopic individuals. If an allergic reaction occurs, amoxicillin/clavulanic acid therapy<br />must be discontinued and appropriate alternative therapy instituted.<br />In the case that an infection is proven to be due to an amoxicillin-susceptible organisms(s)<br />then consideration should be given to switching from amoxicillin/clavulanic acid to<br />amoxicillin in accordance with official guidance.<br />This presentation of CoAmox is not suitable for use when there is a high risk that the<br />presumptive pathogens have resistance to beta-lactam agents that is not mediated by betalactamases<br />susceptible to inhibition by clavulanic acid. This presentation should not be used<br />to treat penicillin-resistant S. pneumoniae.<br />Convulsions may occur in patients with impaired renal function or in those receiving high<br />doses (see section 4.8).<br />Amoxicillin/clavulanic acid should be avoided if infectious mononucleosis is suspected since<br />the occurrence of a morbilliform rash has been associated with this condition following the<br />use of amoxicillin.<br />Concomitant use of allopurinol during treatment with amoxicillin can increase the likelihood<br />of allergic skin reactions.<br />Prolonged use may occasionally result in overgrowth of non-susceptible organisms.<br />The occurrence at the treatment initiation of a feverish generalised erythema associated with<br />pustula may be a symptom of acute generalised exanthemous pustulosis (AGEP) (see section<br />4.8). This reaction requires CoAmox discontinuation and contraindicates any subsequent<br />administration of amoxicillin.<br />Amoxicillin/clavulanic acid should be used with caution in patients with evidence of hepatic<br />impairment (see sections 4.2, 4.3 and 4.8).<br />Hepatic events have been reported predominantly in males and elderly patients and may be<br />associated with prolonged treatment. These events have been very rarely reported in children.<br />In all populations, signs and symptoms usually occur during or shortly after treatment but in<br />some cases may not become apparent until several weeks after treatment has ceased. These<br />are usually reversible. Hepatic events may be severe and, in extremely rare circumstances,<br />deaths have been reported. These have almost always occurred in patients with serious<br />underlying disease or taking concomitant medications known to have the potential for hepatic<br />effects (see section 4.8).<br />Antibiotic-associated colitis has been reported with nearly all antibacterial agents including<br />amoxicillin and may range in severity from mild to life threatening (see section 4.8).<br />Therefore, it is important to consider this diagnosis in patients who present with diarrhoea<br />during or subsequent to the administration of any antibiotics. Should antibiotic-associated<br />colitis occur, amoxicillin/clavulanic acid should immediately be discontinued, a physician be<br />consulted and an appropriate therapy initiated. Anti-peristaltic medicinal products are<br />contraindicated in this situation.</p><p>Periodic assessment of organ system functions, including renal, hepatic and haematopoietic<br />function is advisable during prolonged therapy.<br />Prolongation of prothrombin time has been reported rarely in patients receiving<br />amoxicillin/clavulanic acid. Appropriate monitoring should be undertaken when<br />anticoagulants are prescribed concomitantly. Adjustments in the dose of oral anticoagulants<br />may be necessary to maintain the desired level of anticoagulation (see sections 4.5 and 4.8).<br />In patients with renal impairment, the dose should be adjusted according to the degree of<br />impairment (see section 4.2).<br />In patients with reduced urine output, crystalluria has been observed very rarely,<br />predominantly with parenteral therapy. During the administration of high doses of<br />amoxicillin, it is advisable to maintain adequate fluid intake and urinary output in order to<br />reduce the possibility of amoxicillin crystalluria. In patients with bladder catheters, a regular<br />check of patency should be maintained (see section 4.9).<br />During treatment with amoxicillin, enzymatic glucose oxidase methods should be used<br />whenever testing for the presence of glucose in urine because false positive results may occur<br />with non-enzymatic methods.<br />The presence of clavulanic acid in CoAmox may cause a non-specific binding of IgG and<br />albumin by red cell membranes leading to a false positive Coombs test.<br />There have been reports of positive test results using the Bio-Rad Laboratories<br />Platelia Aspergillus EIA test in patients receiving amoxicillin/clavulanic acid who were<br />subsequently found to be free of Aspergillus infection. Cross-reactions with non-Aspergillus<br />polysaccharides and polyfuranoses with Bio-Rad Laboratories Platelia Aspergillus EIA test<br />have been reported. Therefore, positive test results in patients receiving<br />amoxicillin/clavulanic acid should be interpreted cautiously and confirmed by other<br />diagnostic methods.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Oral anticoagulants<br />Oral anticoagulants and penicillin antibiotics have been widely used in practice without<br />reports of interaction. However, in the literature there are cases of increased international<br />normalised ratio in patients maintained on acenocoumarol or warfarin and prescribed a<br />course of amoxicillin. If co-administration is necessary, the prothrombin time or international<br />normalised ratio should be carefully monitored with the addition or withdrawal of<br />amoxicillin. Moreover, adjustments in the dose of oral anticoagulants may be necessary (see<br />sections 4.4 and 4.8).<br />Methotrexate<br />Penicillins may reduce the excretion of methotrexate causing a potential increase in toxicity.<br />Probenecid<br />Concomitant use of probenecid is not recommended. Probenecid decreases the renal tubular<br />secretion of amoxicillin. Concomitant use of probenecid may result in increased and<br />prolonged blood levels of amoxicillin but not of clavulanic acid.<br />Mycophenolate mofetil<br />In patients receiving mycophenolate mofetil, reduction in pre-dose concentration of the active<br />metabolite mycophenolic acid (MPA) of approximately 50% has been reported following<br />commencement of oral amoxicillin plus clavulanic acid. The change in pre-dose level may<br />not accurately represent changes in overall MPA exposure. Therefore, a change in the dose of<br />mycophenolate mofetil should not normally be necessary in the absence of clinical evidence<br />of graft dysfunction. However, close clinical monitoring should be performed during the<br />combination and shortly after antibiotic treatment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy,<br />embryonal/foetal development, parturition or postnatal development (see section 5.3).<br />Limited data on the use of amoxicillin/clavulanic acid during pregnancy in humans do not<br />indicate an increased risk of congenital malformations. In a single study in women with<br />preterm, premature rupture of the foetal membrane it was reported that prophylactic treatment<br />with amoxicillin/clavulanic acid may be associated with an increased risk of necrotising<br />enterocolitis in neonates. Use should be avoided during pregnancy, unless considered<br />essential by the physician.<br />Breastfeeding<br />Both substances are excreted into breast milk (nothing is known of the effects of clavulanic<br />acid on the breast-fed infant). Consequently, diarrhoea and fungus infection of the mucous<br />membranes are possible in the breast-fed infant, so that breast-feeding might have to be<br />discontinued. The possibility of sensitisation should be taken into account.<br />Amoxicillin/clavulanic acid should only be used during breast-feeding after benefit/risk<br />assessment by the physician in charge.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects on the ability to drive and use machines have been performed.<br />However, undesirable effects may occur (e.g. allergic reactions, dizziness, convulsions),<br />which may influence the ability to drive and use machines (see section 4.8)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The most commonly reported adverse drug reactions (ADRs) are diarrhoea, nausea and<br />vomiting.<br />The following terminologies have been used in order to classify the occurrence of undesirable<br />effects.<br />Very common (&ge;1/10)<br />Common (&ge;1/100 to &lt;1/10)<br />Uncommon (&ge;1/1,000 to &lt;1/100)<br />Rare (&ge;1/10,000 to &lt;1/1,000)<br />Very rare (&lt;1/10,000)<br />Not known (cannot be estimated from the available data)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms and signs of overdose<br />Gastrointestinal symptoms and disturbance of the fluid and electrolyte balances may be<br />evident. Amoxicillin crystalluria, in some cases leading to renal failure, has been observed<br />(see section 4.4).<br />Convulsions may occur in patients with impaired renal function or in those receiving high<br />doses.</p><p>Amoxicillin has been reported to precipitate in bladder catheters, predominantly after<br />intravenous administration of large doses. A regular check of patency should be maintained<br />(see section 4.4).<br />Treatment of intoxication<br />Gastrointestinal symptoms may be treated symptomatically, with attention to the<br />water/electrolyte balance.<br />Amoxicillin/clavulanic acid can be removed from the circulation by haemodialysis.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Combinations of penicillins, incl. beta-lactamase inhibitors;<br />ATC code: J01CR02.<br />Mechanism of action<br />Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more<br />enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway<br />of bacterial peptidoglycan, which is an integral structural component of the bacterial cell<br />wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is<br />usually followed by cell lysis and death.<br />Amoxicillin is susceptible to degradation by beta-lactamases produced by resistant bacteria<br />and therefore the spectrum of activity of amoxicillin alone does not include organisms which<br />produce these enzymes.<br />Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates some betalactamase<br />enzymes thereby preventing inactivation of amoxicillin. Clavulanic acid alone does<br />not exert a clinically useful antibacterial effect.<br />Pharmacokinetic/pharmacodynamic relationship<br />The time above the minimum inhibitory concentration (T&gt;MIC) is considered to be the major<br />determinant of efficacy for amoxicillin.<br />Mechanisms of resistance<br />The two main mechanisms of resistance to amoxicillin/clavulanic acid are:<br />&bull; Inactivation by those bacterial beta-lactamases that are not themselves inhibited by<br />clavulanic acid, including class B, C and D.<br />&bull; Alteration of PBPs, which reduce the affinity of the antibacterial agent for the target.<br />Impermeability of bacteria or efflux pump mechanisms may cause or contribute to bacterial<br />resistance, particularly in Gram-negative bacteria.<br />Breakpoints<br />MIC breakpoints for amoxicillin/clavulanic acid are those of the European Committee on<br />Antimicrobial Susceptibility Testing (EUCAST)</p><p>The prevalence of resistance may vary geographically and with time for selected species, and<br />local information on resistance is desirable, particularly when treating severe infections. As<br />necessary, expert advice should be sought when the local prevalence of resistance is such that<br />the utility of the agent in at least some types of infections is questionable.</p><p>Commonly susceptible species<br />Aerobic Gram-positive micro-organisms<br />Enterococcus faecalis<br />Gardnerella vaginalis<br />Staphylococcus aureus (methicillin-susceptible)<br />Coagulase-negative staphylococci (methicillin-susceptible)<br />&pound;<br />Streptococcus agalactiae<br />Streptococcus pneumoniae<br />Streptococcus pyogenes and other beta-haemolytic streptococci<br />1<br />Streptococcus viridans group<br />Aerobic Gram-negative micro-organisms<br />Capnocytophaga spp.<br />Eikenella corrodens<br />Haemophilus influenzae<br />Moraxella catarrhalis<br />2<br />Pasteurella multocida<br />Anaerobic micro-organisms<br />Bacteroides fragilis<br />Fusobacterium nucleatum<br />Prevotella spp.<br />Species for which acquired resistance may be a problem<br />Aerobic Gram-positive micro-organisms<br />Enterococcus faecium $<br />Aerobic Gram-negative micro-organisms<br />Escherichia coli<br />Klebsiella oxytoca<br />Klebsiella pneumoniae<br />Proteus mirabilis<br />Proteus vulgaris<br />Inherently resistant organisms<br />Aerobic Gram-negative micro-organisms<br />Acinetobacter sp.<br />Citrobacter freundii<br />Enterobacter sp.<br />Legionella pneumophila<br />Morganella morganii<br />Providencia spp.<br />Pseudomonas sp.<br />Serratia sp.<br />Stenotrophomonas maltophilia<br />Other micro-organisms<br />Chlamydophila pneumoniae<br />Chlamydophila psittaci<br />Coxiella burnetti<br />Mycoplasma pneumoniae<br />$ Natural intermediate susceptibility in the absence of acquired mechanism of resistance.<br />&pound; All methicillin-resistant staphylococci are resistant to amoxicillin/clavulanic acid<br />1 Streptococcus pneumoniae that are resistant to penicillin should not be treated with this<br />presentation of amoxicillin/clavulanic acid (see sections 4.2 and 4.4).<br />2 Strains with decreased susceptibility have been reported in some countries in the EU<br />with a frequency higher than 10%.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />Amoxicillin and clavulanic acid, are fully dissociated in aqueous solution at physiological<br />pH. Both components are rapidly and well absorbed by the oral route of administration.<br />Following oral administration, amoxicillin and clavulanic acid are approximately 70%<br />bioavailable. The plasma profiles of both components are similar and the time to peak plasma<br />concentration (Tmax) in each case is approximately one hour.<br />The pharmacokinetic results for a study, in which amoxicillin/clavulanic acid (875 mg/125<br />mg tablets given twice daily) was administered in the fasting state to groups of healthy<br />volunteers.</p><p>Amoxicillin and clavulanic acid serum concentrations achieved with amoxicillin/clavulanic<br />acid are similar to those produced by the oral administration of equivalent doses of<br />amoxicillin or clavulanic acid alone.<br />Distribution<br />About 25% of total plasma clavulanic acid and 18% of total plasma amoxicillin is bound to<br />protein. The apparent volume of distribution is around 0.3-0.4 l/kg for amoxicillin and around<br />0.2 l/kg for clavulanic acid.<br />Following intravenous administration, both amoxicillin and clavulanic acid have been found<br />in gall bladder, abdominal tissue, skin, fat, muscle tissues, synovial and peritoneal fluids, bile<br />and pus. Amoxicillin does not adequately distribute into the cerebrospinal fluid.<br />From animal studies there is no evidence for significant tissue retention of drug-derived<br />material for either component. Amoxicillin, like most penicillins, can be detected in breast<br />milk. Trace quantities of clavulanic acid can also be detected in breast milk (see section 4.6).<br />Both amoxicillin and clavulanic acid have been shown to cross the placental barrier (see<br />section 4.6).<br />Biotransformation<br />Amoxicillin is partly excreted in the urine as the inactive penicilloic acid in quantities<br />equivalent to up to 10 to 25% of the initial dose. Clavulanic acid is extensively metabolized<br />in man and eliminated in urine and faeces and as carbon dioxide in expired air.<br />Elimination<br />The major route of elimination for amoxicillin is via the kidney, whereas for clavulanic acid<br />it is by both renal and non-renal mechanisms.<br />Amoxicillin/clavulanic acid has a mean elimination half-life of approximately one hour and a<br />mean total clearance of approximately 25 l/h in healthy subjects. Approximately 60 to 70% of<br />the amoxicillin and approximately 40 to 65% of the clavulanic acid are excreted unchanged<br />in urine during the first 6 h after administration of single CoAmox 250 mg/125 mg or 500<br />mg/125 mg tablets. Various studies have found the urinary excretion to be 50-85% for<br />amoxicillin and between 27-60% for clavulanic acid over a 24 hour period. In the case of<br />clavulanic acid, the largest amount of drug is excreted during the first 2 hours after<br />administration.<br />Concomitant use of probenecid delays amoxicillin excretion but does not delay renal<br />excretion of clavulanic acid (see section 4.5).<br />Age<br />The elimination half-life of amoxicillin is similar for children aged around 3 months to 2<br />years and older children and adults. For very young children (including preterm newborns) in<br />the first week of life the interval of administration should not exceed twice daily<br />administration due to immaturity of the renal pathway of elimination. Because elderly<br />patients are more likely to have decreased renal function, care should be taken in dose<br />selection, and it may be useful to monitor renal function.<br />Gender<br />Following oral administration of amoxicillin/clavulanic acid to healthy males and female<br />subjects, gender has no significant impact on the pharmacokinetics of either amoxicillin or<br />clavulanic acid.<br />Renal impairment<br />The total serum clearance of amoxicillin/clavulanic acid decreases proportionately with<br />decreasing renal function. The reduction in drug clearance is more pronounced for<br />amoxicillin than for clavulanic acid, as a higher proportion of amoxicillin is excreted via the<br />renal route. Doses in renal impairment must therefore prevent undue accumulation of<br />amoxicillin while maintaining adequate levels of clavulanic acid (see section 4.2).<br />Hepatic impairment<br />Hepatically impaired patients should be dosed with caution and hepatic function monitored at<br />regular intervals.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazard for humans based on studies of safety<br />pharmacology, genotoxicity and toxicity to reproduction.<br />Repeat dose toxicity studies performed in dogs with amoxicillin/clavulanic acid demonstrate<br />gastric irritancy and vomiting, and discoloured tongue.<br />Carcinogenicity studies have not been conducted with amoxicillin/clavulanic acid or its<br />components.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tablet core<br />Colloidal silicon dioxide<br />Crospovidone, dried,<br />Crosslinked carboxymethylcellulose sodium dried<br />Magnesium stearate<br />Microcrystalline Cellulose, dried.<br />Film-coat<br />Hydropropoxycellulose<br />Ethylcellulose<br />Polysorbate<br />Triethylcitrate<br />Titanium dioxide<br />Talc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 Months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30 &deg;C.<br />Keep this medicine out of the sight &amp; reach of children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tablets are packaged in Alu/Alu blister packs, enclosed in a carton. Each pack contains 12<br />tablets.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Acino Pharma AG, Liesberg, Switzerland
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                June 2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>